The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents

Annals of the Academy of Medicine Singapore

Volumn 38, Issue 1, 2009, Pages 15-21

  Fu, Chen Chung ^a,b   Chen, Ming Chen ^a   Li, Yin Ming ^a   Liu, Tso Tsai ^a   Wang, Li Yu ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Adolescents; Non alcoholic fatty liver disease; Obese; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXPERIMENTAL MODEL; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LIVER; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; RANDOM SAMPLE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND; WAIST CIRCUMFERENCE; WEIGHT;

EID: 60049089619     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002;17:1136-43.
2. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003;18:124-38.
3. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver diseases: an agenda for clinical research. Hepatology 2002;35:746-52.
4. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-S112.
5. Hsiao TJ, Chen JC, Wang JD. Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. Int J Obes Relat Metab Disord 2004;28:167-72.
6. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003;18:588-94.
7. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000;24:772-6.
8. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003;9:1106-10.
9. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-7.
10. Liu TY, Lu SN, Su WP, Chang WY, Wang LY, Hsieh MY, et al. Prediction of fatty liver from serum triglyceride levels and body weight indexes. Gaoxiong Yi Xue Ke Xue Za Zhi 1990;6:289-94.
11. Lai SW, Tan CK, Ng KC. Epidemiology of fatty liver in a hospital-based study in Taiwan. South Med J 2002;95:1288-92.
12. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004;28:1257-63.
13. Fishbein MH, Miner M, Mogren C, Chalekson J. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J Pediatr Gastroenterol Nutr 2003;36:54-61.
14. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000;30:48-53.
15. Fu CC, Li YM, Yeh JI, Pei D, Lin HH, Lo HM. Prevalence of overweight adolescents and associated factors in Hualien city. Tzu Chi Med J 2004;16:301-7.
16. Chen W, Lin CC, Peng CT, Li CI, Wu HC, Chiang J, et al. Approaching healthy body mass index norms for children and adolescents from health-related physical fitness. Obes Rev 2002;3:225-32.
17. Chen W, Tsai CY, Chen AC, Wu SF, Lin TW, Lin HC. Growth charts of Taiwanese youth: norms based on health-related physical fitness. Mid Taiwan J Med 2003;8: S85-S93.
18. Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994;5:102-9.
19. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 1986;146:1011-5.
20. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8:97-106.
21. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-5.
22. Chu NF. Prevalence and trends of obesity among school children in Taiwan-the Taipei Children Heart Study. Int J Obes Relat Metab Disord 2001;25:170-6.
23. Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr 1998;67:1141-6.
24. Noguchi H, Tazawa Y, Nishinomiya F, Takada G. The relationship between serum transaminase activities and fatty liver in children with simple obesity. Acta Paediatr Jpn 1995;37:621-5.
25. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40:2002-9.
26. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
27. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161:1413-9.
28. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003;26:16-23.
29. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005;90:1578-82.